Faron Pharmaceuticals Oy - ESG Rating & Company Profile powered by AI
If you work at Faron Pharmaceuticals Oy and you wish to use your ESG aseessment, please contact us. This dashboard includes a questions and answers section about Faron Pharmaceuticals Oy. Comprehensive Sustainability analysis of Faron Pharmaceuticals Oy can be reached by signing up for free.
Faron Pharmaceuticals Oy in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | Faron Pharmaceuticals Oy | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Faron Pharmaceuticals Oy have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose current and historical energy intensity?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy report the average age of the workforce?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose its ethnicity pay gap?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose cybersecurity risks?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy offer flexible work?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy conduct supply chain audits?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Faron Pharmaceuticals Oy conduct 360 degree staff reviews?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose the individual responsible for D&I?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose water use targets?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy have careers partnerships with academic institutions?
Sign up for free to unlockDid Faron Pharmaceuticals Oy have a product recall in the last two years?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose incidents of discrimination?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Faron Pharmaceuticals Oy issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose parental leave metrics?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose the pay ratio of women to men?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Faron Pharmaceuticals Oy involved in embryonic stem cell research?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose its waste policy?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy report according to TCFD requirements?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose energy use targets?
Sign up for free to unlockDoes Faron Pharmaceuticals Oy disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Faron Pharmaceuticals Oy have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Faron Pharmaceuticals Oy
These potential risks are based on the size, segment and geographies of the company.
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also develops Haematokine, a new chemical entity AOC3 inhibitor for the treatment of hematological malignancies and bone marrow. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.